Map of SARS-CoV-2 spike epitopes not shielded by glycans
暂无分享,去创建一个
Gerhard Hummer | Mateusz Sikora | Roberto Covino | Michael Gecht | G. Hummer | M. Sikora | Michael Gecht | Roberto Covino | Florian E. C. Blanc | Sören von Bülow | S. von Bülow | Sören von Bülow
[1] Yiwei Cao,et al. Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane , 2020, The journal of physical chemistry. B.
[2] Alexander D. MacKerell,et al. CHARMM Additive All-Atom Force Field for Glycosidic Linkages between Hexopyranoses. , 2009, Journal of chemical theory and computation.
[3] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997 .
[4] Nicholas C. Wu,et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV , 2020, Science.
[5] Jaap Goudsmit,et al. Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants , 2006, PLoS medicine.
[6] Gerhard Hummer,et al. Coarse-grained models for simulations of multiprotein complexes: application to ubiquitin binding. , 2008, Journal of Molecular Biology.
[7] B. L. de Groot,et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.
[8] Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody , 2020, Science.
[9] Ben M. Webb,et al. Comparative Protein Structure Modeling Using Modeller , 2006, Current protocols in bioinformatics.
[10] P. Masters,et al. The Molecular Biology of Coronaviruses , 2006, Advances in Virus Research.
[11] A. Lupas,et al. Predicting coiled coils from protein sequences , 1991, Science.
[12] W. Im,et al. Automated Builder and Database of Protein/Membrane Complexes for Molecular Dynamics Simulations , 2007, PloS one.
[13] C. Broder,et al. A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein , 2020, bioRxiv.
[14] Alexander D. MacKerell,et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.
[15] F. Rey,et al. Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines , 2018, Cell.
[16] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[17] Ralf Bartenschlager,et al. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography , 2020, Nature Communications.
[18] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.
[19] T. Gallagher,et al. Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence , 2012, Viruses.
[20] Amalio Telenti,et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody , 2020, Nature.
[21] Berk Hess,et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .
[22] T. D. Schneider,et al. Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.
[23] Daniel Wrapp,et al. Site-specific glycan analysis of the SARS-CoV-2 spike , 2020, Science.
[24] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[25] B. Roux,et al. Simulation of Osmotic Pressure in Concentrated Aqueous Salt Solutions , 2010 .
[26] Thomas L. Vincent,et al. LOGICOIL - multi-state prediction of coiled-coil oligomeric state , 2013, Bioinform..
[27] Zachary T. Berndsen,et al. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation , 2020, Nature Communications.
[28] Z. Rao,et al. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody , 2020, Science.
[29] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[30] Rose E Goodchild,et al. The ins and outs of endoplasmic reticulum‐controlled lipid biosynthesis , 2017, EMBO reports.
[31] John A.G. Briggs,et al. Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions , 2020, bioRxiv.
[32] Gary R. Whittaker,et al. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis , 2014, Virus Research.
[33] Beata Turoňová,et al. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges , 2020, Science.
[34] Daniel Wrapp,et al. Site-specific analysis of the SARS-CoV-2 glycan shield , 2020, bioRxiv.
[35] K. Shi,et al. Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.
[36] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[37] John D. Chodera,et al. SARS-CoV-2 Simulations go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome , 2021, Biophysical Journal.
[38] Sunhwan Jo,et al. CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..
[39] Anton Andonov,et al. Architecture of the SARS coronavirus prefusion spike , 2006, Nature Structural &Molecular Biology.
[40] Gerhard Hummer,et al. MDBenchmark: A toolkit to optimize the performance of molecular dynamics simulations. , 2020, The Journal of chemical physics.
[41] M. Parrinello,et al. Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .
[42] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[43] Qiang Zhou,et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 , 2020, Science.
[44] M. Parrinello,et al. Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.
[45] D. Agard,et al. A molecular pore spans the double membrane of the coronavirus replication organelle , 2020, Science.
[46] Sunhwan Jo,et al. CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates , 2019, Glycobiology.
[47] B. Neuman,et al. Supramolecular Architecture of the Coronavirus Particle , 2016, Advances in Virus Research.
[48] Ben M. Webb,et al. Comparative Protein Structure Modeling Using MODELLER , 2007, Current protocols in protein science.
[49] John D. Chodera,et al. SARS-CoV-2 Simulations Go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome , 2020, bioRxiv.
[50] Asif Shajahan,et al. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 , 2020, bioRxiv.
[51] Jeffery B. Klauda,et al. CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. , 2009, Biophysical journal.
[52] Derek N Woolfson,et al. CCBuilder 2.0: Powerful and accessible coiled‐coil modeling , 2017, Protein science : a publication of the Protein Society.
[53] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[54] Kathryn L. Schornberg,et al. Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme , 2008 .
[55] Austin G. Meyer,et al. Maximum Allowed Solvent Accessibilites of Residues in Proteins , 2012, PloS one.
[56] Bjoern Peters,et al. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes , 2017, Nucleic Acids Res..
[57] Young Do Kwon,et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.
[58] William J. Liu,et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 , 2020, Nature.
[59] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[60] D. Burton,et al. Rational Vaccine Design in the Time of COVID-19 , 2020, Cell Host & Microbe.
[61] Rommie E. Amaro,et al. Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein , 2020, bioRxiv.
[62] D. Sheward,et al. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction , 2020, Nature Communications.
[63] S. Harrison,et al. Viral membrane fusion. , 2015, Virology.
[64] Linqi Zhang,et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection , 2020, Nature.
[65] B. Haynes,et al. Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation , 2020, bioRxiv.
[66] Lijun Rong,et al. Solution Structure of the Severe Acute Respiratory Syndrome-Coronavirus Heptad Repeat 2 Domain in the Prefusion State , 2006, Journal of Biological Chemistry.